I‐Ting Yu

472 citations
23 papers · 352 indexed · h-index 12
Topics
Lymphoma Diagnosis and Treatment (4 papers)Sarcoma Diagnosis and Treatment (3 papers)Vascular Tumors and Angiosarcomas (2 papers)
Partner nations
TaiwanUnited States

In The Last Decade

I‐Ting Yu

23 papers receiving 342 citations

Peers

I‐Ting Yu
Comparison fields: 5 of 50
  • Oncology 113
  • Pathology and Forensic Medicine 95
  • Molecular Biology 91
  • Surgery 88
  • Pulmonary and Respiratory Medicine 82
Replace Georg Schwarzkopf with:
Georg Schwarzkopf Germany
R Ricco Italy
Esther Oliva United States
Marjan Daneshpouy France
Eisuke Shiozawa Japan
Noraidah Masir Malaysia
Danuta Skomra Poland
Lisa Lassay Germany
Bruce Addis United Kingdom
Sonja Kiuru‐Kuhlefelt Finland
I‐Ting Yu relative to Georg Schwarzkopf Germany Georg Schwarzkopf's profile →
Citations per field
00.5×1.5×
Georg Schwarzkopf · 1×
Citations per year

Countries citing papers authored by I‐Ting Yu

Since Specialization
Citations

This map shows the geographic impact of I‐Ting Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I‐Ting Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I‐Ting Yu more than expected).

Fields of papers citing papers by I‐Ting Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I‐Ting Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I‐Ting Yu. The network helps show where I‐Ting Yu may publish in the future.

Co-authorship network of co-authors of I‐Ting Yu

This figure shows the co-authorship network connecting the top 25 collaborators of I‐Ting Yu. A scholar is included among the top collaborators of I‐Ting Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I‐Ting Yu. I‐Ting Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 40
2 21
3 65
4 2
5 50
6 9
7 27
8 7
9 13
10 2
11 11
12 4
13 7
14
Genital tuberculosis with peritonitis mimicking Meigs' syndrome: a case report.
6
15 17
16 6
17 3
18 16
19 2
20 11

About I‐Ting Yu

I‐Ting Yu is a scholar working on Gastroenterology, Immunology and Allergy and Genetics, having authored 23 papers that have together received 352 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (4 papers), Sarcoma Diagnosis and Treatment (3 papers) and Vascular Tumors and Angiosarcomas (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (95 citations), Oncology (113 citations) and Genetics (42 citations). I‐Ting Yu has collaborated with scholars based in Taiwan and United States. Frequent co-authors include Hung Chiang, An‐Hang Yang, Chin‐Chen Pan, Donald Ming‐Tak Ho, Liu H, Po‐Min Chen, Jen‐Kou Lin, Ching‐Fen Yang, Jeng‐Kai Jiang and Chiung‐Ru Lai. Their work appears in journals such as Cancer, The Journal of Urology and The American Journal of Surgical Pathology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026